AKH CME: On the Spot Oncology

Share on FacebookTweet about this on TwitterShare on LinkedIn

CME Credit: 0.25 hour activities

While several aspects of therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) have remained unchanged for several decades, new therapeutic options have emerged within the past 5 years, particularly targeted agents. These agents represent a new era for treatment of GEP-NETs, but also create a key area of educational need, as the new data challenge the current paradigm of patient treatment. These activities review the novel treatment choices for improving care in patients diagnosed with GEP-NETs.

Submit a Comment

Your email address will not be published. Required fields are marked *

three × four =